Amgen drug is hit with FDA’s strictest warning

The latest stories trending on MedCity News.

Editor's Pick

Top Story Amgen Osteoporosis Drug Prolia Is Hit With FDA's Strictest Warning The FDA said Amgen's Prolia may lead to low levels of calcium, or hypocalcemia. The osteoporosis drug's black box warning follows an FDA review of Centers for Medicare & Medicaid Services studies that found Prolia led to a significant increase in the risk of severe hypocalcemia compared to treatment with an older class of medicines. Sponsored Content The Benefits Of Adopting a Hyperpersonal Care Model for Patients Presented by AVIA Health This webinar will feature expert panelists from Praia Health and Providence, interviewed by AVIA. They will discuss the benefits of adopting a hyperpersonal care model for patients, barriers that hold health systems back, and will unpack Praia Health's technology capabilities.  Sign up today! Calling Startups - Get More Funding Do you focus on oncology, cardiology, women's health, or burnout and operational efficiency? If so, then apply to pitch at INVEST 2024. There is no fee to apply and each track will feature six finalists. This is the perfect way to make new connections, find investors/get additional funding, and a chance to win $20K in advertising for your startup. Deadline to apply is February 29, 2024. Apply Today

Featured News

Achieving Operational Improvement Through Improved Awareness Levels Exceptional awareness levels help hospitals improve operational efficiency and can also help health systems increase capacity, improve access to care, achieve higher profitability and improve margins. What Are the Challenges in Moving Along Value-Based Care in Rural Communities? Adoption of value-based care has been slower in rural communities. With many rural providers struggling to even stay afloat, it can be difficult to switch to value-based care, according to one healthcare executive. How to Overcome the New Realities in Home Health Budget Strains In navigating fiscal uncertainties, it is essential to acknowledge technology as a powerful ally, securing the resilience and long-term sustainability of home care for generations of patients and caregivers to follow. Where Does the Industry Stand on Virtual-First Health Plans? During a recent webinar, industry leaders agreed that virtual-first health plans have significant potential to cut costs and improve members' experiences — if executed well. They also noted that employers are more willing than ever to adopt these types of plans. Navigating Transformative Trends: Value-Based Care in the Spotlight for 2024 Here are the key trends that will need to be top of mind for provider organizations that are transitioning to VBC, or looking to improve their performance under value-based contracts.

Resources

MedCity FemFwd: Shortcomings in Menopause Care with Dr. Bruce Dorr In this episode, we were joined by Dr. Bruce Dorr, an OB-GYN and senior medical advisor for Biote, a hormone optimization company. Just about every woman will go through menopause, yet treatment is inadequate. This comes down to the lack of medical training for menopause care, according to Dorr. He discusses why this is and what needs to change. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe